The Latest Cardiac and Vascular News
Innovative RhythmStar® technology designed to improve cardiac monitoring for faster arrhythmia detection MOUNT LAUREL, N.J., Feb. 18, 2021 /PRNewswire/ — RhythMedix, a leader in remote cardiac monitoring, today announced the release of its next-generation RhythmStar® wearable device with built-in 4G cellular connectivity. The novel cardiac telemetry monitor is discreetly worn for extended remote monitoring […]
SILVER SPRING, Md., Feb. 17, 2021 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, announced today the first patient enrolled in the HEAL Study, investigating the biologic and clinical […]
Captures ECG and heart rate as a response to treatment for heart, lung, and health problems CAMPBELL, Calif., Feb. 16, 2021 /PRNewswire/ — VivaLNK, a leading provider of connected healthcare solutions, announces availability of a wearable ECG monitoring solution designed to wirelessly capture ECG and heart rate during a six-minute walk test (6MWT). […]
Strategic collaboration leverages AliveCor’s diagnostics and AI capabilities MOUNTAIN VIEW, Calif., Feb. 16, 2021 /PRNewswire/ — AliveCor, the leader in AI-based personal ECG technology and provider of enterprise cardiology solutions, today announced a new collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN), a global science-led biopharmaceutical company, to research new disease management solutions in cardiovascular, renal, and […]
CLAMART, France–(BUSINESS WIRE)–MicroPort CRM, a subsidiary of MicroPort Scientific Corporation (Stock code: 00853.HK), a pioneering company in the field of Cardiac Rhythm Management, has launched an online education website, MicroPort Academy CRM. The website is dedicated to Healthcare Professionals who want to enhance their knowledge about cardiac pacing therapy and […]
AUSTIN, Texas, Feb. 12, 2021 /PRNewswire/ — A physician with the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center is among the first in the world to participate in a clinical trial to evaluate the safety and efficacy of a new cardiac-specific catheter used during pulsed field ablation (PFA), a new approach […]
– The watch will begin shipping in EU as a medical device for continuous measurement of heart rate and arrhythmias at ECG-level accuracy CAESAREA, Israel, Feb. 10, 2021 /PRNewswire/ — CardiacSense – a digital health company that developed and clinically verified a medical grade watch capable of detecting and remotely monitoring Atrial Fibrillation (A-Fib) and Heart […]
PARIS and BOSTON, Feb. 10, 2021 /PRNewswire/ — Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, today announced that results of a clinical study the company conducted in collaboration with Valley Health System have been published in the Journal of the American College of Cardiology Clinical Electrophysiology (“JACC Clinical EP”). The findings show […]
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 10, 2021 /PRNewswire/ — United Therapeutics Corporation (Nasdaq: UTHR) announced today that it has launched commercial sales of the innovative Remunity® Pump for Remodulin® for patients with pulmonary arterial hypertension (PAH). “We are excited to bring to market the first subcutaneous pump designed specifically for PAH patients,” said Beth Rhodes, […]
DURHAM, N.C., Feb. 09, 2021 (GLOBE NEWSWIRE) — Aerami Therapeutics, Inc. (“Aerami” or the “Company”) a clinical stage biopharmaceutical company developing inhaled therapies to treat severe respiratory and chronic diseases today announces the signing of an exclusive license and development agreement with Hangzhou Chance Pharmaceuticals Co. Ltd. (“Chance”) to develop […]
